Ramesa Shafi | Biochemistry | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Ramesa Shafi Bhat
King Saud University, Saudi Arabia
Ramesa Shafi Bhat
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57442927600
Documents 105
Citations 1,896
h-index 25
Subject Area Biochemistry
Event World Top Scientist Awards
ORCID 0000-0003-2149-6239

Ramesa Shafi Bhat is a researcher affiliated with King Saud University in Saudi Arabia, with research interests spanning biochemistry, nanomedicine, and biomarkers. Her academic profile reflects contributions across multiple areas of biomedical and biochemical research, supported by a substantial body of scholarly publications and research activities. [1]

Abstract

This academic recognition profile presents the documented research record of Ramesa Shafi Bhat, affiliated with King Saud University, Saudi Arabia. The profile is centered on biochemistry and related biomedical research areas, with the supplied bibliographic record indicating work involving nanomedicine, biomarkers, oxidative stress, microbiology, cancer biology, nutritional interventions, and experimental models. The available ORCID record also documents a substantial portfolio of scholarly works and research-review activity. [1]

Keywords

Biochemistry; Nanomedicine; Biomarkers; Nanoparticles; Oxidative Stress; Antimicrobial Activity; Cancer Biology; Molecular Biology; Microbiology; Nutritional Science; Gut Microbiota; Biomedical Research.

Introduction

The researcher profile identifies Ramesa Shafi Bhat as an academic researcher at King Saud University in Riyadh, Saudi Arabia. The ORCID record lists biochemistry, nanomedicine, and biomarkers as associated keywords and records King Saud University as the employment affiliation. These details provide the institutional and disciplinary context for evaluating the research portfolio represented in the available scholarly record. [1]

Research Profile

The supplied research profile contains a broad body of publications associated with biochemical and biomedical investigations. Examples include studies of sodium-halide stress in plant systems, fluoride-associated oxidative stress, antimicrobial and antibiofilm activity, nanoparticle-mediated biological effects, and molecular investigations of cancer. The range of topics indicates an interdisciplinary research portfolio connecting biochemical mechanisms with applied biomedical and environmental questions. [5]

Research Contributions

The record also includes biomedical research related to cancer, biomarkers, inflammatory mechanisms, and neurobiological conditions. Examples include research on breast-cancer biomarkers, colorectal-cancer molecular profiles, cancer-cell responses, and experimental models associated with autism-related biochemical changes. These publications illustrate the breadth of the portfolio while remaining grounded in the specific works documented in the researcher record.[1]

Publications

Representative publications include research on copper oxide nanoparticle biosynthesis, sodium fluoride-related cellular effects, nutritional interventions, microbial activity, and molecular biomarkers. The diversity of journals represented in the record reflects publication across biochemistry, pharmacology, microbiology, nutrition, molecular biology, and related biomedical fields. The following references provide directly accessible DOI pathways for selected publications documented in the supplied ORCID record. [3]

Research Impact

The ORCID record provides an additional persistent researcher identifier and documents the association between Ramesa Shafi Bhat, King Saud University, and the scholarly works presented in the profile. It also records peer-review activity across numerous journals, including publications in molecular, microbiological, nutritional, chemical, and biomedical areas. Together, these records provide complementary evidence for assessing research activity and scholarly engagement. [1]

Award Suitability

For consideration under the Innovative Research Award category, the documented portfolio contains several features relevant to a research-recognition assessment, including sustained publication activity, interdisciplinary subject coverage, identifiable DOI-linked publications, and a research profile spanning biochemistry and related biomedical fields. The supplied bibliometric information may also be considered as supporting quantitative evidence, subject to independent verification from the current Scopus record. [1]

Conclusion

Ramesa Shafi Bhat’s documented research profile is associated with King Saud University and the disciplinary area of biochemistry, with additional work extending into nanomedicine, biomarkers, microbiology, cancer research, nutritional science, and experimental biomedical research. The available ORCID record provides a persistent identity record and a substantial publication history, while the supplied bibliometric information identifies a Scopus profile with 105 documents, 1,896 citations, and an h-index of 25. [1]

References

  1. Al-Dbass, A. M., Al-Daihan, S., Alharbi, M. S., & Bhat, R. S. (2026). Biological activities and host-response insights of Ocimum basilicum flower-derived silver nanoparticles. Inorganics, 14(8), 216. DOI: https://doi.org/10.3390/inorganics14080216
  2. Balto, H., Bekhit, M. S., Auda, S. H., Elansary, A., Bhat, R. S., Marraiki, N., & Al-Hadlaq, S. (2024). Synergistic effect of Salvadora persica and chitosan nanoparticles against oropharyngeal microorganisms. Scientific Reports. DOI: https://doi.org/10.1038/s41598-024-63636-1
  3. Bhat, R. S., Alonazi, M., Al-Dbass, A. M., & Al-Daihan, S. (2024). The impact of varying sizes of silver nanoparticles on the induction of cellular damage in Klebsiella pneumoniae involving diverse mechanisms. Green Processing and Synthesis. DOI: https://doi.org/10.1515/GPS-2024-0162
  4. Bhat, R. S., Al-Dbass, A. M., Khayyat, A. I. A., & Al-Daihan, S. (2024). Utilizing biomolecule-rich citrus fruit waste as a medium for the eco-friendly preparation of silver nanoparticles with antimicrobial properties. Inorganics, 12(7), 180. DOI: https://doi.org/10.3390/inorganics12070180
  5. Ahmed, E. A., Bhat, R. S., Shaik, J. P., Alanazi, M., Al Amri, A., Aldbass, A., & Al Daihan, S. (2024). MicroRNA gene expression profile of colorectal cancer in Saudi population. International Journal of Pharmacology. DOI: https://doi.org/10.3923/ijp.2024.149.157

Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Researcher at Uppsala university, Sweden

Dr. Bhavna Rani is an accomplished molecular and cell biologist with over a decade of research experience spanning academia and industry across Europe. Her work focuses on cancer biology, stem cells, and cell signaling, employing advanced techniques such as 10X CITE-seq, click chemistry, and high-resolution imaging. She has held postdoctoral positions at prestigious institutions including Uppsala University and the Karolinska Institute, contributing to high-impact research and authoring numerous peer-reviewed publications. Dr. Rani is also actively involved in teaching and mentoring at both master’s and doctoral levels and has received research grants and recognition for her scientific contributions. Her multidisciplinary expertise includes project management, business innovation, and sustainability practices gained through academic-industry collaborations. Fluent in English and proficient in Swedish, she demonstrates strong communication and leadership skills through her roles in scientific committees and postdoctoral associations. Driven by innovation and collaboration, Dr. Rani is committed to advancing biomedical research and its translational applications.

Professional Profile 

ORCID Profile

Education

Dr. Bhavna Rani holds a Marie Curie-funded Ph.D. in Surgical and Experimental Sciences and Cellular Therapies from the University of Bari, Italy, where she conducted translational cancer research focusing on TGF-beta inhibitors in hepatocellular carcinoma. Prior to that, she completed a top-tier Master’s program (M.Sc.) in Oncology from Vrije University, Amsterdam, Netherlands, gaining a solid foundation in cancer biology and experimental therapeutics. She also holds additional certifications in Intellectual Property Law, Research Ethics, Leadership, Sustainability, and Health Policy from prestigious institutions like Uppsala University and Karolinska Institute. These certifications reflect her commitment to continuous learning and her interdisciplinary approach to research. Her diverse educational background across multiple countries has provided her with strong analytical, theoretical, and ethical frameworks, making her well-equipped for advanced scientific research and academic leadership. This comprehensive education forms the backbone of her successful career in molecular biology and translational research.

Professional Experience

Dr. Bhavna Rani has amassed extensive research experience across leading European institutions. She is currently a researcher at Uppsala University, where she works on centrosome clustering and cancer therapeutics. Previously, she was a postdoctoral researcher at the Karolinska Institute, focusing on integrin signaling in stem cells using 10X CITE-seq and advanced 3D culture models. Her career includes multiple postdoctoral roles in Sweden, Italy, Germany, and Spain, covering areas such as MEK therapy resistance in pancreatic cancer and tumor microenvironment imaging using MRI techniques. She has also gained biotech industry experience during her internship at Key2Brain AB, contributing to Alzheimer’s disease models and sustainability protocols. Additionally, she has been involved in scientific advisory roles, market analysis, and mentoring master’s students. Her professional journey highlights her interdisciplinary expertise, international collaborations, and ability to navigate both academic and industrial research environments effectively.

Research Interest

Dr. Bhavna Rani’s research interests lie at the intersection of molecular cell biology, cancer therapeutics, and regenerative medicine. She is particularly focused on understanding the mechanisms of cytokinesis, centrosome clustering, and cell adhesion in both normal and cancerous cells. Her work extends into integrin-mediated signaling, stem cell biology, and the tumor microenvironment, utilizing tools such as 10X CITE-seq, click chemistry, and 3D scaffolds. She is passionate about translating basic cellular mechanisms into therapeutic strategies, especially in targeting cancer stemness, drug resistance, and abnormal cell division. Her interest in translational science is also evident in her past research on liver regeneration and MEK resistance pathways, as well as her involvement in preclinical studies on Alzheimer’s disease. Through a combination of molecular techniques, imaging, and biomaterial sciences, Dr. Rani aims to develop targeted interventions that improve disease outcomes and patient care in oncology and regenerative medicine.

Award and Honor

Dr. Bhavna Rani has received notable recognition throughout her academic and research career. She was a prestigious Marie Curie Fellow during her Ph.D., an award reserved for top-tier researchers in the EU. Her research has been funded by competitive grants such as the A&M Rudberg and Marcus and Amalia Wallenberg Foundation, acknowledging the impact and promise of her scientific contributions. She has served as a reviewer for peer-reviewed journals like Cancer Medicine, further establishing her authority in the biomedical field. Additionally, she has been an active member of scientific societies, including the European Association for the Study of the Liver (EASL) and the European Society for Clinical Investigation (ESCI). She also held leadership roles in postdoctoral associations at Uppsala University and Karolinska Institute. While her list of named awards could expand, her consistent record of grants, fellowships, and leadership roles reflect strong academic recognition.

Conclusion

Dr. Bhavna Rani is a highly accomplished and driven biomedical researcher whose career spans cutting-edge research in cancer biology, stem cells, and regenerative medicine. With a strong academic foundation and wide-ranging professional experience in both academia and industry, she demonstrates a rare blend of scientific excellence, teaching expertise, and interdisciplinary collaboration. Her research has real-world impact, particularly in understanding complex cellular processes like cytokinesis and integrin signaling in disease contexts. She has contributed to multiple peer-reviewed publications and secured competitive funding, affirming the value of her work. Beyond the lab, she actively participates in teaching, mentoring, and scientific communities, showcasing leadership and commitment to the broader research ecosystem. With her deep expertise, innovative thinking, and collaborative mindset, Dr. Rani is exceptionally well-positioned to continue making meaningful contributions to science and society. Her profile makes her a strong candidate for research awards and future leadership roles in biomedical research.

Publications Top Notes

  • Cytokinesis in Suspension: A Distinctive Trait of Mesenchymal Stem Cells

    • Authors: Rani B, Qian H, Johansson S

    • Year: 2025

  • Contribution of Integrin Adhesion to Cytokinetic Abscission and Genomic Integrity

    • Authors: Rani B, Gupta DK, Johansson S, Kamranvar SA

    • Year: 2022

  • Cell Cycle Regulation by Integrin‑Mediated Adhesion

    • Authors: Kamranvar SA, Rani B, Johansson S

    • Year: 2022

  • Platelets as Key Factors in Hepatocellular Carcinoma

    • Authors: Pavlovic N, Rani B, Gerwins P, Heindryckx F

    • Year: 2019

  • Galunisertib Suppresses the Staminal Phenotype in Hepatocellular Carcinoma by Modulating CD44 Expression

    • Authors: Rani B, Malfettone A, Dituri F, et al.

    • Year: 2018

  • Transforming Growth Factor‑β‑Induced Plasticity Causes a Migratory Stemness Phenotype in Hepatocellular Carcinoma

    • Authors: Malfettone A, Soukupova J, Rani B, et al.

    • Year: 2017

  • MicroRNA‑199a‑5p Inhibition Enhances the Liver Repopulation Ability of Human Embryonic Stem Cell‑Derived Hepatic Cells

    • Authors: Möbus S, Yang D, Yuan Q, Lüdtke TH, Rani B, et al.

    • Year: 2014

  • Moving Towards Personalised Therapy in Patients with Hepatocellular Carcinoma: The Role of the Microenvironment

    • Authors: Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G

    • Year: 2014

  • Role of the Tissue Microenvironment as a Therapeutic Target in Hepatocellular Carcinoma

    • Authors: Rani B, Cao Y, Malfettone A, Tomuleasa C, et al.

    • Year: 2014

  • MicroRNA‑221 Overexpression Accelerates Hepatocyte Proliferation During Liver Regeneration

    • Authors: Yuan Q, Loya K, Rani B, Möbus S, et al.

    • Year: 2013